USPTO serial 79218099
GNA
Reviewed by CopyMark Law Group
Reg. 5667692Status 709
- Filing date
- Status date
- Registration date
- Feb 5, 2019
- Examiner
- THOMAS, JULIE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with GNA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jacqueline Zion
Jacqueline Zion Pearl Cohen Zedek Latzer Baratz LLP1500 Broadway, 12th FLNew York, NY 10036UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical substances for analyses in laboratories, other than for medical or veterinary purposes; chemical preparations for scientific purposes, other than for medical or veterinary use; detergents for use in manufacturing processes for diagnostic reagents; enzymes for industrial purposes; enzyme preparations for industrial purposes; gold salts; preparations of microorganisms, other than for medical and veterinary use, namely, for conducting bioanalytical reference measurements, or preparations serving as positive control reagents in bioanalytical procedures ; diagnostic reagents for scientific or research use for sale in kit form; biochemical for in vitro and in vivo scientific use; chemicals for use in immuno-assay testing other than medical or veterinary; chemicals for use in performing nucleic acid polymerase chain reactions other than medical or veterinary; chemical diagnostic reagents for industrial use; chemical products for diagnostic use, namely, diagnostic for scientific purposes; chemicals for use in multiplying nucleic acid amounts other than for medical or veterinary use; chemical reagents for use in analytical tests, other than for medical or veterinary use; chemical reagents for use in diagnostic tests, other than for medical or veterinary use; chemical reagents for molecular biology, other than for medical or veterinary use; chemical reagents for laboratory use, other than for medical or veterinary use; chemical reagents for use with immunoassay analyzers, other than for medical or veterinary use; diagnostic kits comprising specimen receptors and reagents for testing for selected bacteria for scientific use; diagnostic preparations for scientific purposes; diagnostic preparations, other than for medical or veterinary purposes; diagnostic reagents for in-vitro use other than medical; diagnostic reagents, other than for medical laboratory use; diagnostic substances, other than for medical use; diagnostic chemicals other than for medical or veterinary use; diagnostic chemicals for use in antibiotic susceptibility testing other than for medical use; in-vivo diagnostic reagents for scientific use; diagnostic preparations for scientific or research use other than for medical use; diagnostic testing materials, other than for medical use; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; diagnostic reagents, except for medical or veterinary use; diagnostic reagents for scientific or research use; diagnostic reagents for scientific use; immunoassay reagents, other than for medical use; clinical diagnostics, other than for medical or veterinary use; nucleic acids for laboratory use; nucleic acid for use in nucleic acid amplification processes other than for medical use; reagents for use in analytical tests other than for medical or veterinary purposes; reagents for use in biological processing other than for medical or veterinary purposes; reagents for use in diagnostic tests other than for medical or veterinary purposes; reagents for laboratory purposes other than for medical or veterinary purposes; reagents for in-vitro laboratory use other than for medical or veterinary purposes; reagents for testing the sterility of medical equipment; nucleic acid amplification reagents other than for medical use; nucleic recombinant acids for laboratory use | SECTION 71 - CANCELLED | — |
| 005 | Diagnostic chemical reagents for medical use; chemical reagents for medical or veterinary purposes; diagnostic preparations for medical purposes; diagnostic agents for pharmaceutical use; diagnostic preparations for veterinary purposes; diagnostic biomarker reagents for medical purposes; diagnostic testing materials for medical use testing of the intended performance characteristics of bioanalytical methods ; diagnostic reagents for medical use; clinical medical reagents; reagents for in-vitro laboratory use for medical purposes; reagents for in-vitro laboratory use for veterinary purposes; reagents for microbiological analysis for medical purposes; reagents for microbiological analysis for veterinary purposes; reagents for use in diagnostic tests for medical purposes; reagents for use with analyzers for veterinary purposes; reagents for use with analyzers for medical purpose | SECTION 71 - CANCELLED | — |
| 009 | Biochips for research or scientific purposes; diagnostic apparatus, not for medical purposes, namely, for bioanalytical purposes, in particular for nucleic acid amplification and detection; computer software applications, downloadable, for setting up, conducting, interpreting, and storing bioanalytical measurements, in particular for nucleic acid amplification and detection; lasers, not for medical purposes; chemistry apparatus and instruments, namely, for bioanalytical procedures; recorded computer programs for setting up, conducting interpreting, and storing bioanalytical measurements, in particular for nucleic acid amplification and detection; downloadable computer software programs for setting up, conducting, interpreting, and storing bioanalytical measurements, in particular for nucleic acid amplification and detection; recorded computer software for setting up, conducting, interpreting, and storing bioanalytical measurements, in particular for nucleic acid amplification and detection; DNA chips; air analysis apparatus; optical apparatus and instruments, namely, for bioanalytical measurements; laboratory equipment, namely, test tubes; probes for scientific purposes for conducting bioanalytical measurements, in particular for nucleic acid amplification and detection; scientific, electrotechnical, electronic, optical, measuring, signaling, checking, and supervision apparatus and instruments, namely, for conducting bioanalytical procedures, in particular sample preparation, nucleic acid amplification and detection; laboratory apparatus, analysis apparatus and parts therefor, namely, for conducting bioanalytical procedures, in particular sample preparation, nucleic acid amplification and detection; scanners; laboratory equipment, in particular apparatus for bioanalysis, in particular temperature cyclers, fluorescence scanners and apparatuses for nucleic acid amplification and detection, in particular using a cartridge for preparing samples, purifying nucleic acids and amplifying nucleic acids and for detecting nucleic acids; disposable articles for laboratory apparatus, in particular sample and receptacles, mainly consisting of plastic; parts and fittings for all the aforesaid, namely, mechanical, electrical, and structural modules or components | SECTION 71 - CANCELLED | — |
| 010 | Apparatus for DNA and RNA exams for medical purposes; blood testing apparatus; diagnostic apparatus for medical purposes for detecting target molecules of interest in a sample, in particular a patient sample; lasers for medical purposes; medical apparatus, in particular apparatus for bioanalysis, namely, the extraction, amplification, and detection of target molecules of interest; diagnostic apparatus for veterinary purposes for detecting target molecules of interest; automatic analyzers for medical diagnosis for detecting target molecules of interest; medical apparatus and instruments, namely, for detecting target molecules of interest; medical instruments for infectious disease testing, namely, human or veterinary pathogens; medical and veterinary apparatus and instruments, namely, for processing samples, and detecting target molecules of interest; tools for veterinary diagnostics, namely, detecting target molecules of interest | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by GNA Biosolutions GmbH
- Other trademarks owned by GNA Biosolutions GmbH
- Other trademarks owned by GNA Biosolutions GmbH
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Similar marks named GNA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 22, 2026 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Aug 22, 2025 | C71T | CANCELLED SECTION 71 | — |
| Feb 5, 2024 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Oct 9, 2020 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 21, 2019 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 31, 2019 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 30, 2019 | FIMP | FINAL DISPOSITION PROCESSED | — |
| May 5, 2019 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 5, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 20, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 20, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 16, 2018 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Oct 31, 2018 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 31, 2018 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Oct 31, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 11, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 11, 2018 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 11, 2018 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 11, 2018 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 11, 2018 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 4, 2018 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Aug 4, 2018 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 4, 2018 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 9, 2018 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Jun 26, 2018 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Jun 9, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 24, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 23, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 23, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 23, 2018 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 17, 2017 | RFNP | REFUSAL PROCESSED BY IB | — |
| Nov 29, 2017 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 29, 2017 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 15, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 14, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 28, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 17, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 13, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 12, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |